Marc Tardieu

Author PubWeight™ 94.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007 5.86
2 Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006 4.26
3 Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2008 2.87
4 Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 2010 2.47
5 Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis 2004 2.46
6 Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 2012 2.32
7 International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013 2.20
8 Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med 2007 1.96
9 Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007 1.89
10 Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest 2011 1.88
11 Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003 1.88
12 Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS 2006 1.85
13 Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 2003 1.82
14 Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2010 1.75
15 Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007 1.73
16 Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 2011 1.71
17 N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 2013 1.55
18 Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol 2006 1.49
19 First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004 1.48
20 Intrathecal treatment of anti-N-Methyl-D-aspartate receptor encephalitis in children. Dev Med Child Neurol 2014 1.47
21 Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 2006 1.39
22 Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med 2012 1.35
23 Gene therapy of the brain in the dog model of Hurler's syndrome. Ann Neurol 2006 1.32
24 Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment. Clin Infect Dis 2003 1.31
25 MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004 1.31
26 Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat 2009 1.28
27 Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 2011 1.26
28 Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans. Curr Opin Allergy Clin Immunol 2007 1.26
29 Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes. Mol Ther 2010 1.23
30 Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J Pediatr 2010 1.21
31 HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era. Brain Pathol 2003 1.14
32 Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer. Neurology 2013 1.07
33 Human alpha-iduronidase gene transfer mediated by adeno-associated virus types 1, 2, and 5 in the brain of nonhuman primates: vector diffusion and biodistribution. Hum Gene Ther 2009 1.06
34 Expanding spectrum of encephalitis with NMDA receptor antibodies in young children. J Child Neurol 2009 1.06
35 Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 2007 1.01
36 Ischaemic stroke from dissection of the craniocervical arteries in childhood: report of 12 patients. Eur J Paediatr Neurol 2003 0.97
37 Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol 2011 0.97
38 Systematic search for neutropenia should be part of the first screening in patients with poikiloderma. Eur J Med Genet 2011 0.95
39 The management of multiple sclerosis in children: a European view. Mult Scler 2010 0.95
40 Acute transverse myelitis in children: clinical course and prognostic factors. J Child Neurol 2003 0.94
41 CCR5-, DC-SIGN-dependent endocytosis and delayed reverse transcription after human immunodeficiency virus type 1 infection in human astrocytes. AIDS Res Hum Retroviruses 2006 0.93
42 Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol 2011 0.93
43 Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis. J Neurol 2015 0.92
44 Magnetic resonance angiography in childhood arterial brain infarcts: a comparative study with contrast angiography. Stroke 2002 0.91
45 Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics 2006 0.90
46 Intrafamilial variability in the phenotypic expression of adenylosuccinate lyase deficiency: a report on three patients. Am J Med Genet A 2003 0.89
47 Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation. Eur J Neurosci 2004 0.89
48 International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology 2013 0.89
49 Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity. Blood 2004 0.89
50 Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients. Blood 2009 0.89
51 Hashimoto's encephalopathy: identification and long-term outcome in children. Eur J Paediatr Neurol 2012 0.88
52 Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: a comparative cohort study. Eur J Paediatr Neurol 2007 0.88
53 Centropontine myelinolysis related to refeeding syndrome in an adolescent suffering from anorexia nervosa. Neuropediatrics 2012 0.87
54 New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur Neurol 2004 0.86
55 Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. Neurosci Lett 2006 0.85
56 Clinically observed chickenpox and the risk of childhood-onset multiple sclerosis. Am J Epidemiol 2009 0.85
57 Clinical mitochondrial dysfunction in uninfected children born to HIV-infected mothers following perinatal exposure to nucleoside analogues. Environ Mol Mutagen 2007 0.85
58 Differential regulation of gelatinase A and B and TIMP-1 and -2 by TNFalpha and HIV virions in astrocytes. Microbes Infect 2004 0.85
59 Human cytomegalovirus infection reduces surface CCR5 expression in human microglial cells, astrocytes and monocyte-derived macrophages. Microbes Infect 2002 0.84
60 Opsoclonus-myoclonus in children associated or not with neuroblastoma. Eur J Paediatr Neurol 2010 0.83
61 The risk of very long-term brain dysfunction in treated adolescents with perinatally acquired HIV-1 infection. AIDS 2009 0.83
62 Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms. Orphanet J Rare Dis 2012 0.82
63 Stroke due to lyme neuroborreliosis: changes in vessel wall contrast enhancement. J Neuroimaging 2010 0.82
64 Decompressive craniectomy in children with nontraumatic refractory high intracranial pressure. Clinical article. J Neurosurg Pediatr 2009 0.81
65 Ultrasonographic rotator-cuff changes in veteran tennis players: the effect of hand dominance and comparison with clinical findings. Eur Radiol 2003 0.81
66 Interferon-alpha triggers B cell effector 1 (Be1) commitment. PLoS One 2011 0.81
67 Genotype-phenotype correlation in 13q13.3-q21.3 deletion. Eur J Med Genet 2011 0.80
68 Changes in cerebral energy metabolites induced by impact-acceleration brain trauma and hypoxic-hypotensive injury in rats. J Neurotrauma 2006 0.78
69 Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent. J Neurovirol 2010 0.78
70 Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 2007 0.77
71 Spectrum of MECP2 mutations in Rett syndrome. Genet Test 2002 0.77
72 School performance in a cohort of children with CNS inflammatory demyelination. Eur J Paediatr Neurol 2010 0.76
73 How well can MRI predict MS in children with acute disseminated encephalomyelitis? Neurology 2010 0.75
74 Environmental factors, brain development, and intelligence in adulthood. Ann Neurol 2009 0.75
75 Predictors of multiple sclerosis in children and implications for early initiation of treatment. Lancet Neurol 2011 0.75
76 Creatine and guanidinoacetate reference values in a French population. Mol Genet Metab 2013 0.75
77 [The hospital and the child, the hospital otherwise... the action of a passionate, Daniel Alagille]. Arch Pediatr 2006 0.75
78 [Genetic predisposition to herpetic meningo-encephalitis in children]. Bull Acad Natl Med 2010 0.75
79 Extracranial vertebral artery dissection in children: natural history and management. Neuroradiology 2015 0.75
80 EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates. Eur J Paediatr Neurol 2012 0.75